GTR Test Accession:
Help
GTR000137034.4
Last updated in GTR: 2015-11-26
View version history
GTR000137034.4, last updated: 2015-11-26
GTR000137034.3, last updated: 2014-11-26
GTR000137034.2, last updated: 2013-11-26
GTR000137034.1, last updated: 2013-11-26
Last annual review date for the lab: 2021-01-29
Past due
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Pre-symptomatic; ...
Conditions (1):
Help
Friedreich ataxia 1
Genes (1):
Help
FXN (9q21.11)
Methods (1):
Help
Molecular Genetics - Targeted variant analysis: Trinucleotide repeat by PCR or Southern Blot
Target population: Help
Ataxia patients
Clinical validity:
Help
Not provided
Clinical utility:
Help
Establish or confirm diagnosis
Ordering Information
Offered by:
Help
Test short name:
Help
FRDA, Friedreich ataxia
Specimen Source:
Help
- Isolated DNA
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Physician
Test Order Code:
Help
28-3
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Completion of the laboratory referral letter by the referring physician/scientist. Provision of a signed informed consent form. Both forms are available on the laboratory website.
Order URL
Order URL
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
Test additional service:
Help
Custom Prenatal Testing
Custom mutation-specific/Carrier testing
Custom mutation-specific/Carrier testing
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
Yes
Pre-test genetic counseling required:
Help
Yes
Post-test genetic counseling required:
Help
Yes
Recommended fields not provided:
Lab contact for this test,
Test strategy
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Genes
Help
Total genes: 1
Gene | Associated Condition | Germline or Somatic | Allele (Lab-provided) | Variant in NCBI |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Targeted variant analysis
Trinucleotide repeat by PCR or Southern Blot
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Pre-symptomatic;
Risk Assessment
Clinical utility:
Help
Establish or confirm diagnosis
View citations (2)
- Bidichandani SI, Delatycki MB. Friedreich Ataxia. 1998 Dec 18 [updated 2017 Jun 01]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024. PMID: 20301458.
- https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/books/NBK1281
Target population:
Help
Ataxia patients
View citations (2)
- Recent advances in the molecular pathogenesis of Friedreich ataxia. Puccio H, et al. Hum Mol Genet. 2000;9(6):887-92. doi:10.1093/hmg/9.6.887. PMID: 10767311.
- The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Filla A, et al. Am J Hum Genet. 1996;59(3):554-60. PMID: 8751856.
Recommended fields not provided:
Clinical validity,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
[1] PCR based detection of the GAA trinucleotide repeat size in the first intron of the frataxin (FXN) gene on chromosome 9q13. A long PCR protocol as described by Filla et al (1996) is followed. [2] PCR amplification and automated sequence analysis of the above trinucleotide repeat. The primer sequences …
View more
View citations (2)
- Recent advances in the molecular pathogenesis of Friedreich ataxia. Puccio H, et al. Hum Mol Genet. 2000;9(6):887-92. doi:10.1093/hmg/9.6.887. PMID: 10767311.
- The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Filla A, et al. Am J Hum Genet. 1996;59(3):554-60. PMID: 8751856.
Test Confirmation:
Help
different method or new sample
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
99% precise
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
European Molecular Genetics Quality Network, EMQN
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
European Molecular Genetics Quality Network, EMQN
Recommended fields not provided:
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
Not Applicable
Additional Information
Clinical resources:
Molecular resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.